Nicardipine Hydrochloride Injection Recalled for Sterility Assurance Concerns
American Regent, Inc. is recalling Nicardipine Hydrochloride Injection (25 mg/10 mL) in one lot due to lack of assurance of sterility. The recall affects approximately 4,136 cartons distributed in Utah.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall without reported illnesses or hospitalizations; precautionary recall due to sterility assurance concerns without confirmed contamination, fitting the 'voluntary precautionary recalls' criterion at severity score 2.
Plain-English summary
American Regent, Inc. is recalling Nicardipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL) due to lack of assurance of sterility. The affected product is lot number 23087N0C0 with expiration date 11/2024 (NDC 72572-470-10). Approximately 4,136 cartons, each containing 10 single-dose vials, were distributed in Utah.
The recalled product was manufactured by American Regent, Inc., New Albany, OH for Civica, Inc., Lehi, UT. Nicardipine Hydrochloride Injection is an intravenous medication prescribed for blood pressure management.
Persons who have received this medication should contact their healthcare provider with questions about their current medication. Healthcare facilities should identify and quarantine remaining product with lot number 23087N0C0.
This recall was initiated by American Regent, Inc. at the request of the FDA. For more information about this recall, contact the FDA Drug Safety office or the recalling manufacturer.
The recalled product
- Product
- NICARDIPINE HYDROCHLORIDE (NICARDIPINE HYDROCHLORIDE)
- Brand
- NICARDIPINE HYDROCHLORIDE
- Manufacturer
- American Regent, Inc.
- Category
- Drug — Cardiovascular Injection
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 23087N0C0
- Exp. Date 11/2024
Distribution
Distributed in 1 state:
Related recalls
Same brand · NICARDIPINE HYDROCHLORIDE
- SevereFDA Recalls Nicardipine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereNicardipine Hydrochloride Injection Recalled for Potential Sterility Issues
FDA (Drugs) · 2025-05-07
- SevereNicardipine Hydrochloride Injection Recalled for Potential Sterility Loss
FDA (Drugs) · 2025-05-07
- HighNicardipine Hydrochloride Injection Recalled for Out-of-Specification Organic Impurities
FDA (Drugs) · 2024-03-27
- HighNicardipine Hydrochloride Injection Recalled Due to Out-of-Specification Organic Impurities
FDA (Drugs) · 2024-03-27
Same manufacturer · American Regent, Inc.
See all →- SevereAmerican Regent Recalls Multrys Trace Elements Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Atropine Sulfate Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Acetylcysteine Solution Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAminocaproic Acid Injection Recalled for Particulate Matter Contamination
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26
Same hazard · contamination
See all →- HighMedline Recalls Gynecologic Robotic Surgery Kits Due to Contamination
FDA (Devices) · 2026-09-02
- HighMedline Recalls 263 Surgical Convenience Kits Due to Contamination
FDA (Devices) · 2026-09-02
- HighMedline recalls surgical convenience kits due to potential contamination
FDA (Devices) · 2026-09-02
- HighMedline Recalls 663 Surgical Convenience Kits Due to Contamination
FDA (Devices) · 2026-09-02
- HighMedline Recalls 71 Convenience Kits Due to Contaminated Component
FDA (Devices) · 2026-09-02